CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Clinical trials for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CANCER TREATMENT-INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cord blood infusion aims to rescue cancer Patients' platelet counts
Disease control Recruiting nowThis study tests if a single infusion of umbilical cord blood can safely raise platelet levels in cancer patients whose platelets dropped due to chemotherapy or other cancer drugs. About 25 people aged 12 to 65 will receive the infusion and be monitored for 28 days. The goal is t…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 26, 2026 10:09 UTC
-
New drug aims to fix chemo side effect and keep cancer treatment on track
Symptom relief Recruiting nowThis study tests an experimental drug called QL0911 for cancer patients whose platelet levels drop too low after chemotherapy. Low platelets can delay treatment and cause bleeding risks. The trial will compare the drug to a placebo in 235 adults aged 18-75 to see if it safely rai…
Matched conditions: CANCER TREATMENT-INDUCED THROMBOCYTOPENIA
Phase: PHASE2, PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated May 22, 2026 14:04 UTC